# Effectiveness Study of the Guardian RT in Type 1 Diabetics

> **NCT01331343** · PHASE4 · COMPLETED · sponsor: **Medtronic MiniMed, Inc.** · enrollment: 156 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DEVICE:** Guardian RT Telemetered Glucose Monitoring System

## Key facts

- **NCT ID:** NCT01331343
- **Lead sponsor:** Medtronic MiniMed, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2005-06
- **Final completion:** 2005-06
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2011-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01331343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01331343, "Effectiveness Study of the Guardian RT in Type 1 Diabetics". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01331343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*